Opus Genetics (IRD) Cash from Investing Activities (QoQ) (2010 - 2019)
Opus Genetics (IRD) Cash from Investing Activities (QoQ) (2010 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Opus Genetics |
355.39 Mn |
295.43 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2019 |
-104.12% |
| Sep 30, 2019 |
0.21% |
| Jun 30, 2019 |
150.78% |
| Mar 31, 2019 |
-394.76% |
| Dec 31, 2018 |
-45.42% |
| Sep 30, 2018 |
12.79% |
| Jun 30, 2018 |
8.39% |
| Mar 31, 2018 |
197.87% |
| Dec 31, 2017 |
-202.21% |
| Sep 30, 2017 |
129.91% |
| Jun 30, 2017 |
-1,510.17% |
| Mar 31, 2017 |
-84.82% |
| Dec 31, 2016 |
345.47% |
| Sep 30, 2016 |
-176.96% |
| Jun 30, 2016 |
423.23% |
| Mar 31, 2016 |
82.08% |
| Dec 31, 2015 |
-161.46% |
| Sep 30, 2015 |
164.08% |
| Jun 30, 2015 |
-37.79% |
| Mar 31, 2015 |
289.66% |
